<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The distribution and pathological significance of <z:chebi fb="0" ids="37550">sphingosine-1-phosphate</z:chebi> receptor 1 expression are still unclear </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we evaluated <z:chebi fb="0" ids="37550">sphingosine-1-phosphate</z:chebi> receptor 1's suitability as a diagnostic marker for malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> by immunostaining formalin-fixed paraffin-embedded sections using a well-defined commercial anti-<z:chebi fb="0" ids="37550">sphingosine-1-phosphate</z:chebi> receptor 1 antibody </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="37550">Sphingosine-1-phosphate</z:chebi> receptor 1 was strongly expressed on the surface of small lymphocytes forming primary lymphoid follicles and in the mantle zone of secondary lymphoid follicles </plain></SENT>
<SENT sid="3" pm="."><plain>Microarray-based immunohistochemistry with tissue samples from 85 lymphoid <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> cases demonstrated that <z:chebi fb="0" ids="37550">sphingosine-1-phosphate</z:chebi> receptor 1 was expressed on the surface of mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells </plain></SENT>
<SENT sid="4" pm="."><plain>Strong expression was observed in <z:hpo ids='HP_0000001'>all</z:hpo> classical mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cases involving the lymph node (19 out of 19), gastrointestinal tract (10 out of 10), bone marrow (9 out of 9), and orbita (1 out of 1) </plain></SENT>
<SENT sid="5" pm="."><plain>Good results were obtained even in sections where cyclin D1 signals were lost because of over-fixation and/or <z:mpath ids='MPATH_48'>decalcification</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>One aggressive variant of mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> displayed a weaker membranous staining than classical mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in the lymph node and bone marrow </plain></SENT>
<SENT sid="7" pm="."><plain>In a cyclin D1-negative mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> of the orbita, no conclusive result was obtained </plain></SENT>
<SENT sid="8" pm="."><plain>No cases of follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, marginal zone <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, B lymphoblastic <z:hpo ids='HP_0001909'>leukemia</z:hpo>/<z:hpo ids='HP_0002665'>lymphoma</z:hpo>, or Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> showed any significant expression, whereas 2 out of 6 <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo>/small lymphocytic <z:hpo ids='HP_0002665'>lymphomas</z:hpo> in bone marrow, 1 out of 3 lymphoplasmacytic <z:hpo ids='HP_0002665'>lymphomas</z:hpo> in the lymph node, and 2 out of 37 diffuse large B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> exhibited staining </plain></SENT>
<SENT sid="9" pm="."><plain>A quantitative reverse transcription polymerase chain reaction-based analysis of mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> lines revealed the <z:chebi fb="0" ids="37550">sphingosine-1-phosphate</z:chebi> receptor 1 mRNA expression level to be well correlated with the results of immunocytochemistry, flow cytometry, and western blotting </plain></SENT>
<SENT sid="10" pm="."><plain>Thus, <z:chebi fb="0" ids="37550">sphingosine-1-phosphate</z:chebi> receptor 1 immunohistochemistry may be useful in the histological diagnosis of mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> with formalin-fixed and paraffin-embedded sections </plain></SENT>
<SENT sid="11" pm="."><plain>The antigen may be particularly valuable in cases where cyclin D1 immunostaining is not successful </plain></SENT>
</text></document>